To verify our hypothesis that circulating peptides (i.e., C3f-derived fragments) can function as reliable indicators of a cancer-associated proteolytic event for prognostic purposes, we employed an ovarian cancer mouse model that can be induced through implantation of the docetaxel-resistant ovarian cancer cell line HeyA8-MDR. Here, LPCAT3 is linked to cancer.